Go to the list of all blogs
Sergey Savastiouk's Avatar
published in Blogs
Nov 02, 2026
TickeronGET DAILY SIGNALS
Estée Lauder (EL) Delivers +125% EPS Growth and Raises Full-Year Outlook

Estée Lauder (EL) Delivers +125% EPS Growth and Raises Full-Year Outlook

Key Takeaways

  • Estée Lauder reported adjusted diluted earnings per share (EPS) of $0.72, up 125% from $0.32 a year earlier and well above the roughly $0.51 consensus estimate.
  • Net sales rose about 7% year over year to $3.72 billion, with organic net sales up 6%.
  • Fragrance was the standout, with organic sales up 20%, while Skin Care rose 4%, Makeup grew 1%, and Hair Care was roughly flat.
  • Gross margin expanded 240 basis points to 75.7%, and adjusted operating margin widened 480 basis points to 12.1%.
  • Management raised its full-year fiscal 2027 outlook for organic sales growth, operating margin, and adjusted EPS.
  • For more context on this ticker's Major News, Today's Price Move, Price Targets, and Forecast, explore the dedicated pages for additional detail.
  • Discover Trending AI Robots to see AI-driven trading strategies currently gaining traction in the market.

Why This Quarter Matters

Estée Lauder's fiscal 2027 first quarter serves as an important checkpoint for the company's "Beauty Reimagined" turnaround strategy. After a long period of soft sales and margin pressure, the beauty giant has now delivered five consecutive quarters of organic sales growth and margin expansion. The latest results suggest the recovery could be broadening beyond its strongest brands. From what I see, investors are watching closely because the combination of accelerating fragrance demand, progress in mainland China, and disciplined cost management tests whether management can turn these tailwinds into lasting, diversified growth.

Breaking Down the Reported Results

For the fiscal first quarter ended September 30, 2026, Estée Lauder (EL) reported net sales of $3.72 billion, up about 7% year over year, with organic net sales growth of 6%. Adjusted diluted EPS came in at $0.72, a 125% increase from $0.32 in the prior-year period and above consensus estimates of approximately $0.51. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.

Profitability improved markedly. Gross margin expanded 240 basis points to 75.7%, while adjusted operating margin widened 480 basis points to 12.1%. Management attributed the gains to sales leverage, strategic pricing, procurement savings, and manufacturing efficiencies. Fragrance led category growth with a 20% organic increase, driven by Le Labo, TOM FORD, Jo Malone London, and KILIAN PARIS. Skin Care rose 4%, Makeup grew 1% (its second consecutive quarter of organic growth), and Hair Care was flat.

Geographically, growth was broad-based, with mainland China up 9% organically and priority emerging markets up 15%. The company also raised its full-year fiscal 2027 guidance, now projecting organic net sales growth of 4.0% to 5.5% (up from 3% to 5%) and adjusted diluted EPS of $3.20 to $3.45 (up from $3.10 to $3.35).

Market Reaction and Investor Sentiment

Shares of Estée Lauder (EL) moved higher in premarket trading following the release, as investors responded to the earnings beat and the raised full-year outlook. The market's favorable reaction reflected both the size of the EPS outperformance and management's confidence in sustained momentum. Sentiment was tempered somewhat by the fact that the full-year organic sales guidance, at 4.0% to 5.5%, still sits below the 6% growth delivered in the first quarter, with management signaling that growth is expected to be stronger in the first half of the fiscal year due to the timing of product launches and easier comparisons.

Forward Outlook and Key Factors to Monitor

Looking ahead, investors will focus on whether Estée Lauder (EL) can sustain its recovery as favorable comparisons fade. Management has been explicit that the first half of fiscal 2027 should grow faster than the second half, given the phasing of innovation and a higher base in travel retail later in the year.

One key area to watch is the durability of the fragrance boom. The company's 20% organic growth in the category was powered by luxury brands and new launches, and the rollout of the Estée Lauder Glimmer fragrance into additional markets is a potential catalyst. In parallel, investors will monitor whether Skin Care momentum broadens beyond La Mer and The Ordinary.

Cost discipline and margin execution also remain central. The company's Profit Recovery and Growth Plan is expected to deliver the vast majority of its run-rate benefits by the end of fiscal 2027, while the newer "One ELC" operating model is intended to generate ongoing efficiency. Commodity and freight inflation could pressure margins in the back half of the year.

Finally, geographic dynamics matter. Mainland China has delivered seven consecutive quarters of market share gains, and the recent completion of the Forest Essentials acquisition strengthens the company's position in India's fast-growing prestige beauty market. Geopolitical risks, including the Middle East conflict and potential tariff impacts, remain watchpoints that management has flagged in its outlook assumptions. I’m watching this closely as the story develops.

Integrating Tickeron AI Tools Into My Process

In my research process, I often turn to Tickeron’s AI Screener to filter opportunities across sectors and quickly surface names showing similar technical patterns or fundamental momentum. It helps me cross-check earnings trends against broader market signals without spending hours on manual screens. The tool’s customizable filters for industry, volatility, and AI-driven signals make it a practical addition when evaluating results like these.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: EL

Contributor

Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.


Aroon Indicator for EL shows an upward move is likely

EL's Aroon Indicator triggered a bullish signal on November 02, 2026. Tickeron's A.I.dvisor detected that the AroonUp green line is above 70 while the AroonDown red line is below 30. When the up indicator moves above 70 and the down indicator remains below 30, it is a sign that the stock could be setting up for a bullish move. Traders may want to buy the stock or look to buy calls options. A.I.dvisor looked at 214 similar instances where the Aroon Indicator showed a similar pattern. In 139 of the 214 cases, the stock moved higher in the days that followed. This puts the odds of a move higher at 65%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for EL just turned positive on October 09, 2026. Looking at past instances where EL's MACD turned positive, the stock continued to rise in 26 of 48 cases over the following month. The odds of a continued upward trend are 54%.

EL moved above its 50-day moving average on October 09, 2026 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for EL crossed bullishly above the 50-day moving average on October 14, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 7 of 15 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 47%.

Following a +1.02% 3-day Advance, the price is estimated to grow further. Considering data from situations where EL advanced for three days, in 182 of 282 cases, the price rose further within the following month. The odds of a continued upward trend are 65%.

Bearish Trend Analysis

The 10-day RSI Indicator for EL moved out of overbought territory on October 16, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 29 similar instances where the indicator moved out of overbought territory. In 25 of the 29 cases, the stock moved lower in the following days. This puts the odds of a move lower at 86%.

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 39 of 57 cases where EL's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 68%.

The Momentum Indicator moved below the 0 level on November 02, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on EL as a result. In 67 of 82 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 82%.

EL broke above its upper Bollinger Band on October 15, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is 7 (best 1 - 100 worst), indicating outstanding price growth. EL’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is 16 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is 83 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Seasonality Score of 95 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Valuation Rating of 99 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (9.959) is normal, around the industry mean (20.672). EL's P/E Ratio (209.540) is considerably higher than the industry average of (16.840). Projected Growth (PEG Ratio) (2.121) is also within normal values, averaging (1.518). Dividend Yield (0.013) settles around the average of (0.033) among similar stocks. P/S Ratio (2.317) is also within normal values, averaging (1.902).

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. EL’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 87, placing this stock worse than average.

Notable companies

The most notable companies in this group are Procter & Gamble Company (NYSE:PG), Colgate-Palmolive Company (NYSE:CL).

Industry description

Household/Personal Care companies sell products for home cleaning and/or personal hygiene and grooming purposes. Products of this industry include detergents, shampoos, soaps, cosmetics, fabric conditioners and infant care fragrances. Procter & Gamble, Unilever, Estee Lauder and Colgate-Palmolive are some of the biggest names in the business. A lot of the products become a necessary part of people’s daily routine, and therefore the industry is relatively less vulnerable to macroeconomic downturns. At the same time, product quality, consumer safety, and ease of use are extremely critical factors for a company to survive competition and earn recognition in this industry.

Market Cap

The average market capitalization across the Household/Personal Care Industry is 24.66B. The market cap for tickers in the group ranges from 60.48K to 379.9B. PG holds the highest valuation in this group at 379.9B. The lowest valued company is EOSS at 60.48K.

High and low price notable news

The average weekly price growth across all stocks in the Household/Personal Care Industry was -1%. For the same Industry, the average monthly price growth was 1%, and the average quarterly price growth was 8%. SLSN experienced the highest price growth at 11%, while FRTT experienced the biggest fall at -26%.

Volume

The average weekly volume growth across all stocks in the Household/Personal Care Industry was 169%. For the same stocks of the Industry, the average monthly volume growth was 148% and the average quarterly volume growth was 27%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 52
P/E Growth Rating: 50
Price Growth Rating: 51
SMR Rating: 73
Profit Risk Rating: 87
Seasonality Score: 18 (-100 ... +100)
View a ticker or compare two or three
EL
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a company which offers skin care, makeup, fragrance and hair care products

Industry HouseholdPersonalCare

Industry
Household Or Personal Care
Address
767 Fifth Avenue
Phone
+1 212 572-4200
Employees
55000
Web
https://www.elcompanies.com
Interact to see
Advertisement
The Bitwise Solana Staking ETF (BSOL) advanced roughly 18% over the trailing 30 days, closely tracking a sharp rally in Solana (SOL). The move extends a broader recovery, with BSOL up approximately 77% over the past three months from its mid-2026 trough.
MSTY is an actively managed single-stock option income ETF (exchange-traded fund) that writes call options on Strategy (MSTR), formerly MicroStrategy, to generate current income. The portfolio is anchored by U.S. Treasury bills and MSTR option contracts rather than a diversified basket of equities, concentrating exposure in one volatile underlying.
AMDL has surged roughly +64% over the past 30 days, from about $47.59 to $78.10, mirroring a powerful rally in its sole underlying stock, AMD . The fund is a leveraged single-stock ETF (exchange-traded fund) designed to deliver 2x the daily return of AMD, amplifying both gains and losses.
Shares of Brookfield Infrastructure Corporation (BIPC) are down approximately 11% on Wednesday, trading near $35.44 after closing at $39.82 on April 28, following the release of Q1 2026 earnings before the market open. Primary catalyst: Q1 2026 results showed a GAAP net loss of $61 million, a sharp reversal from net income of $125 million in Q1 2025 — a $186 million year-over-year deterioration.
Shares of Regeneron Pharmaceuticals (REGN) are down approximately 6% on Wednesday, trading near $688 after closing at $731.77 on April 28, in an earnings-driven selloff despite a headline beat on both EPS and revenue. Primary catalyst: A sharp "beat and sell" market reaction driven by the continued deterioration of the core EYLEA franchise — total U.S. EYLEA HD and EYLEA net sales declined 10% year-over-year to $941 million, more than offsetting record Dupixent growth.